金沢大学医学部附属病院　核医学診断科

1983.4 - 1992.12

Relationship between the tau protein and choroid plexus volume in Alzheimer's disease

Ota M, Sato N, Nakaya M, Shigemoto Y, Kimura Y, Chiba E, Yokoi Y, Tsukamoto T, Matsuda H

Neuroreport.   34 ( 11 )   546 - 550   2023.8

Development of software for measuring brain amyloid accumulation using 18 F-florbetapir PET and calculating global Centiloid scale and regional Z-score values

Matsuda H, Soma T, Okita K, Shigemoto Y, Sato N

Brain Behav   13 ( 7 )   2023.7

Clinico-imaging features of subjects at risk of Lewy body disease in NaT-PROBE baseline analysis

Hattori M, Hiraga K, Satake Y, Tsuboi T, Tamakoshi D, Sato M, Yokoi K, Suzuki K, Arahata Y, Hori A, Kawashima M, Shimizu H, Matsuda H, Kato K, Washimi Y, Katsuno M

NPJ Parkinsons Dis   9 ( 1 )   67   2023.4

Correlation between the regional brain volume and glymphatic system activity in progressive supranuclear palsy

Ota M, Sato N, Takahashi Y, Shigemoto Y, Kimura Y, Nakaya M, Chiba E, Matsuda H

Dement Geriatr Cogn Disord   2023.3

Age and Sex-Related Effects on Single-Subject Gray Matter Networks in Healthy Participants

Shigemoto Y, Sato N, Maikusa N, Sone D, Ota M, Kimura Y, Chiba E, Okita K, Yamao T, Nakaya M, Maki H, Arizono E, Matsuda H

J Pers Med   13 ( 3 )   419   2023.2

SPECT・PET.Alzheimer病（AD）　

松田博史

Clinical Neuroscience   41 ( 9 )   1157 - 1161   2023

側頭葉てんかんのMRI診断（非正規分布拡散MRI）

曽根大地、松田博史

41 ( 6 )   866 - 868   2023

Tau positron emission tomography in patients with cognitive impairment and suspected Alzheimer's disease

Matsuda H, Yamao T

Fukushima J Med Sci   69 ( 2 )   85 - 93   2023

Upper cerebellar glucose hypermetabolism in patients with temporal lobe epilepsy and interictal psychosis

Sone D, Sato N, Shigemoto Y, Kimura Y, Matsuda H

Epilepsia Open   657 - 664   2022.12

Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer's disease: a multicenter study

Matsuda H, Okita K, Motoi Y, Mizuno T, Ikeda M, Sanjo N, Murakami K, Kambe T, Takayama T, Yamada K, Suehiro T, Matsunaga K, Yokota T, Tateishi U, Shigemoto Y, Kimura Y, Chiba E, Kawashima T, Tomo Y, Tachimori H, Kimura Y, Sato N

Ann Nucl Med   36 ( 12 )   1039 - 1049   2022.12

18F-THK5351 positron emission tomography imaging for Gerstmann-Sträussler-Scheinker disease

Hama Y, Saitoh Y, Imabayashi E, Morimoto Y, Tsukamoto T, Sato K, Kitamoto T, Mizusawa H, Matsuda H, Takahashi Y

J Neurol Sci   2022.10

Japan Parkinson's Progression Markers Initiative (J-PPMI) study group. Idiopathic rapid eye movement sleep behavior disorder in Japan: An observational study

Nishikawa N, Murata M, Hatano T, Mukai Y, Saitoh Y, Sakamoto T, Hanakawa T, Kamei Y, Tachimori H, Hatano K, Matsuda H, Taruno Y, Sawamoto N, Kajiyama Y, Ikenaka K, Kawabata K, Nakamura T, Iwaki H, Kadotani H, Sumi Y, Inoue Y, Hayashi T, Ikeuchi T, Shimo Y, Mochizuki H, Watanabe H, Hattori N, Takahashi Y, Takahashi R

Parkinsonism Relat Disord   103   129 - 135   2022.10

Non-standard pipeline without MRI has replicability in computation of Centiloid scale values for PiB and 18F-labeled amyloid PET tracers

Fujishima M, Matsuda H.

Neuroimage: Reports 2   2022.9

18F-THK5351 PET for visualizing predominant lesions of pathologically confirmed corticobasal degeneration presenting with frontal behavioral-spatial syndrome

Saitoh Y, Imabayashi E, Mizutani M, Tsukamoto T, Hasegawa M, Saito Y, Matsuda H, Takahashi Y.

J Neurol   5157 - 5161   2022.9

Dopamine dysfunction in depression: application of texture analysis to dopamine transporter single-photon emission computed tomography imaging

Tamura T, Sugihara G, Okita K, Mukai Y, Matsuda H, Shiwaku H, Takagi S, Daisaki H, Tateishi U, Takahashi H

Transl Psychiatry   12 ( 1 )   2022.8

Dopamine dysfunction in depression: application of texture analysis to dopamine transporter single-photon emission computed tomography imaging

Tamura T, Sugihara G, Okita K, Mukai Y, Matsuda H, Shiwaku H, Takagi S, Daisaki H, Tateishi U, Takahashi H

ransl Psychiatry   12 ( 1 )   2022.8

Relationship Between Vitamin D Status and Brain Perfusion in Neuropsychiatric Lupus

Sultana N, Sarkar AK, Matsuda H, Ihsan MA, Haq SA, Arefin MS, Islam SN

Nucl Med Mol Imaging   56 ( 3 )   158 - 168   2022.6

Potential treat-to-target approach for methamphetamine use disorder: a pilot study of adenosine 2A receptor antagonist with positron emission tmography

Okita K, Matsumoto T, Funada D, Murakami M, Kato K, Shigemoto Y, Sato N, Matsuda H

Front Pharmacol   2022.5

Software development for quantitative analysis of brain amyloid PET

Matsuda H, Yamao T

Brain Behav   12 ( 3 )   2022.3

Voxel-based analysis of age and gender effects on striatal [123I] FP-CIT binding in healthy Japanese adults

Shigemoto Y, Matsuda H, Kimura Y, Chiba E, Ohnishi M, Nakaya M, Maikusa N, Ogawa M, Mukai Y, Takahashi Y, Sako K, Toyama H, Inui Y, Taki Y, Nagayama H, Ono K, Kono A, Sekiguchi K, Hirano S, Sato N

Ann Nucl Med   36 ( 5 )   460 - 467   2022.3

The accuracy of T1-weighted voxel-wise and region-wise metrics for brain age estimation.

Iman Beheshti, Norihide Maikusa, Hiroshi Matsuda.

Comput Methods Programs Biomed.   214   106585   2022.2

SPECT,画像診断

松田　博史

日本臨床増刊号「最新臨床脳卒中学（第2版）上」   67   973 - 981   2022.1（ ISSN:00471852 ）

The accuracy of T1-weighted voxel-wise and region-wise metrics for brain age estimation

Beheshti I, Maikusa N, Matsuda H

Comput Methods Programs Biomed   2022

Relationships Between the Deposition of Amyloid-β and Tau Protein and Glymphatic System Activity in Alzheimer's Disease: Diffusion Tensor Image Study

Ota M, Sato N, Nakaya M, Shigemoto Y, Kimura Y, Chiba E, Yokoi Y, Tsukamoto T, Matsuda H

J Alzheimers Dis   295 - 303   2022

特集・認知症の画像診断アップデート　脳内ネットワーク解析

重本蓉子、松田博史

MEDICAL IMAGING TECHNOLOGY   40 ( 3 )   103 - 107   2022

MRIによるNODDI,構造ネットワーク

松田博史、曽根大地、重本蓉子、佐藤典子

脳年齢Dementia Japan   36 ( 3 )   416 - 422   2022

Easy Z-score imaging system (eZIS)とvoxel-based Specific Regional analysis system for Alzheimer’s Disease (VSRAD)開発の経緯

松田博史

臨床放射線   67   973 - 981   2022

Amyloid PET quantification using low-dose CT-guided anatomic standardization.

Hiroshi Matsuda, Tensho Yamao, Mitsuru Shakado, Yoko Shigemoto, Kyoji Okita, Noriko Sato.

EJNMMI Res.   11 ( 1 )   125   2021.12

Determining the extent of tumor resection at surgical planning with 18F-fluciclovine PET/CT in patients with suspected glioma: multicenter phase III trials. Ann Nucl Med.

Toshihiko Wakabayashi, Yuichi Hirose, Keisuke Miyake, Yoshiki Arakawa, Naoki Kagawa, Tadashi Nariai, Yoshitaka Narita, Ryo Nishikawa, Naohiro Tsuyuguchi, Tadateru Fukami, Hikaru Sasaki, Takashi Sasayama, Akihide Kondo, Toshihiko Iuchi, Hiroshi Matsuda, Kazuo Kubota, Ryogo Minamimoto, Takashi Terauchi, Yoichi Nakazato, Kan Kubomura, Masatoshi Wada.

Ann Nucl Med.   35 ( 12 )   1279 - 1292   2021.12

Is Generalized and Segmental Dystonia Accompanied by Impairments in the Dopaminergic System?.

Jun Ikezawa, Fusako Yokochi, Ryoichi Okiyama, Satoko Kumada, Maya Tojima, Tsutomu Kamiyama, Takashi Hanakawa, Hiroshi Matsuda, Fumiaki Tanaka, Yasuhiro Nakata, Eiji Isozaki.

Front Neurol.   12   751434   2021.11

Histopathological validation and clinical correlates of hippocampal subfield volumetry based on T2-weighted MRI in temporal lobe epilepsy with hippocampal sclerosis.

Masashi Mizutani, Daichi Sone, Terunori Sano, Yukio Kimura, Norihide Maikusa, Yoko Shigemoto, Yuichi Goto, Masaki Takao, Masaki Iwasaki, Hiroshi Matsuda, Noriko Sato, Yuko Saito.

Epilepsy Res.   177   106759   2021.11

Single-subject gray matter networks in temporal lobe epilepsy patients with hippocampal sclerosis.

Yoko Shigemoto, Noriko Sato, Daichi Sone, Norihide Maikusa, Tensho Yamao, Yukio Kimura, Emiko Chiba, Fumio Suzuk, Hiroyuki Fujii, Yutaro Takayama, Masaki Iwasaki, Eiji Nakagawa, Hiroshi Matsuda.

Epilepsy Res.   177   106766   2021.11

Accurate lateralization and classification of MRI-negative 18F-FDG-PET-positive temporal lobe epilepsy using double inversion recovery and machine-learning.

Iman Beheshti, Daichi Sone, Norihide Maikusa, Yukio Kimura, Yoko Shigemoto, Noriko Sato, Hiroshi Matsuda.

Comput Biol Med.   137   104805   2021.10

Effects of an Adenosine A2A Receptor Antagonist on Striatal Dopamine D2-Type Receptor Availability: A Randomized Control Study Using Positron Emission Tomography.

Kyoji Okita, Koichi Kato, Yoko Shigemoto, Noriko Sato, Toshihiko Matsumoto, Hiroshi Matsuda.

Front Neurosci.   15   729153   2021.9

brain structural connectome

松田博史、重本蓉子、佐藤典子

Clinical Neuroscience   39 ( 8 )   1048 - 1050   2021.8

Voxel-based correlation of 18F-THK5351 accumulation with gray matter structural networks in cognitively normal older adults.

Yoko Shigemoto, Daichi Sone, Norihide Maikusa, Yukio Kimura, Fumio Suzuki, Hiroyuki Fujii, Noriko Sato, Hiroshi Matsuda.

eNeurologicalSci.   23   2021.4

Prefrontal network dysfunctions in rapid eye movement sleep behavior disorder.

Noritaka Wakasugi, Hiroki Togo, Yohei Mukai, Noriko Nishikawa, Takashi Sakamoto, Miho Murata, Yuji Takahashi, Hiroshi Matsuda, Takashi Hanakawa.

Parkinsonism Relat Disord.   85   72 - 77   2021.4

A Japanese Multicenter Study on PET and Other Biomarkers for Subjects with Potential Preclinical and Prodromal　Alzheimer's　Disease.

M Senda, K Ishii, K Ito, T Ikeuchi, H Matsuda, T Iwatsubo, A Iwata, R Ihara, K Suzuki, K Kasuga, Y Ikari, Y Niimi, H Arai, A Tamaoka, Y Arahata, Y Itoh, H Tachibana, Y Ichimiya, S Washizuka, T Odawara, K Ishii, K Ono, T Yokota, A Nakanishi, E Matsubara, H Mori, H Shimada.

J Prev Alzheimers Dis.   8 ( 4 )   495 - 502   2021

A Japanese Multicenter Study on PET and Other Biomarkers for Subjects with Potential Preclinical and Prodromal Alzheimer's Disease

M Senda 1, K Ishii, K Ito, T Ikeuchi, H Matsuda, T Iwatsubo, A Iwata, R Ihara, K Suzuki, K Kasuga, Y Ikari, Y Niimi, H Arai, A Tamaoka, Y Arahata, Y Itoh, H Tachibana, Y Ichimiya, S Washizuka, T Odawara, K Ishii, K Ono, T Yokota, A Nakanishi, E Matsubara, H Mori, H Shimada

J Prev Alzheimers Dis   2021

Centiloid scale measure of amyloid PET by CT-guided anatomic standardization

Alzheimer’s Association International Conference   2022.7  

アミロイドPETの読影と定量

PETサマーセミナ－2022  

3次元T1強調画像により測定したスモールワールド性の認知症予防における意義

第31回日本脳ドック学会総会　シンポジウム2、認知症、頭部MRIによる認知症診断Update  

Amyloid and Tau PET in Alzheimer’s disease

Joint Symposium on Nuclear Cardiology and Neurology Taiwan Society of Nuclear Medicine 2022   2022.6  

New Trends in Amyloid and Tau PET in Alzheimer’s disease

2022.5  

Quantitative evaluation and its clinical impact of amyloid PET

The 5th Conference of Asia-Pacific Aging Protection  

最新PET（薬剤及び装置）、シンポジウム、南東北病院における最先端医療

第42回日本臨床薬理学会学術総会  

新規MRI計測・解析技術の認知症への応用

NODDI, 脳年齢、脳構造ネットワーク、第40回日本認知症学会学術集会、シンポジウム8  

人間ドックにおけるMRIによる脳年齢および脳萎縮測定

第40回日本認知症学会学術集会  

低線量CTを用いた解剖学的標準化によるアミロイドPET定量

第61回日本核医学会学術総会  

アミロイドPET定量ソフトウェアの開発

第61回日本核医学会学術総会  

Reading and quantification of Amyloid PET

Emirates International Virtual Conference in Nuclear Medicine, Molecular Imaging, and Theranostics  

Voxel-based correlation of 18F-THK5351 accumulation with gray matter structural networks in cognitively normal older adults

Alzheimer’s Association International Conference 2021  

認知症予防のための健常者レジストリIROOP

第62回日本神経学会学術大会